0001209191-22-010717.txt : 20220217 0001209191-22-010717.hdr.sgml : 20220217 20220217160939 ACCESSION NUMBER: 0001209191-22-010717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220215 FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chee Conley CENTRAL INDEX KEY: 0001883804 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 22648144 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 35 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-15 0 0001556263 Syros Pharmaceuticals, Inc. SYRS 0001883804 Chee Conley C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 0 1 0 0 Chief Commercial Officer Stock Option (right to buy) 1.59 2022-02-15 4 A 0 100000 0.00 A 2032-02-14 Common Stock 100000 100000 D Restricted Stock Units 2022-02-15 4 A 0 80000 0.00 A Common Stock 80000 80000 D This option becomes exercisable as to one quarter (1/4th) of the shares on February 28, 2023, with the remainder vesting in monthly installments equal to one forty-eighth (1/48th) of the original number of shares at the end of each of the next thirty-six (36) months thereafter. Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock. These RSUs will vest in four equal annual installments commencing on March 31, 2023. /s/ Gerald E. Quirk, as attorney-in-fact 2022-02-17